Morning Buzz: Heron Therapeutics (HRTX), Goldman (GS), Yahoo (YHOO), Harley-Davidson (HOG)

Shares of Heron Therapeutics, Inc. (HRTX) are higher by 17.50% to $25.25 in pre-market trading on Tuesday after the company announced that the FDA has indicated that there are no substantive deficiencies in the New Drug Application for SUSTOL and has begun labeling discussions with the company. — Goldman Sachs Group, Inc. (GS) shares are […] View the full post at: Morning Buzz: Heron Therapeutics (HRTX), Goldman (GS), Yahoo (YHOO), Harley-Davidson (HOG) Related posts: Harley Davidson: First Loss in 16 Years Goldman Sachs Triples its Profits Goldman Reaps Over $100M A Day On 36 Days in Q3